EdwardChuMD

Gastrointestinal Cancer, Clinical Pharmacology

Director, Albert Einstein Cancer Center, Vice-President of Cancer Medicine, Professor of Medicine and Molecular Pharmacology, Carol and Roger Einiger Professor of Cancer Medicine

Join to view full profile

Dr. Chu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chu's full profile

Already have an account?

Office
1300 Morris Park Ave
Chanin Building, Room 209
Bronx, NY 10461
Phone+1 718-430-2302

Fax+1 718-430-8550

Education & Training

Brown UniversityInternship, Internal Medicine, 1983 - 1984
The Warren Alpert Medical School of Brown UniversityClass of 1983

Certifications & Licensure

NY State Medical License 2023 - 2025
PA State Medical License 2010 - 2024
CT State Medical License 1996 - 2016
RI State Medical License 1987 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Associations of Health Care Utilization and Therapeutic Alliance in Patients with Advanced Cancer.
Sarah G Bell, Andrew D Althouse, Shane C Belin, Robert M Arnold, Kenneth J Smith
Journal of Palliative Medicine. 2024-04-01
mutation and DSS treatment synergize to induce cecal tumor formation in mice.
Chenxi Gao, Farzad Esni, Edward Chu, Jing Hu
Biochemistry and Biophysics Reports. 2024-03-01
FAK loss reduces BRAF-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation.
Chenxi Gao, Huaibin Ge, Shih-Fan Kuan, Chunhui Cai, Xinghua Lu
Research Square. 2024-01-05

Lectures

Completion of adjuvant chemotherapy with Cape/CAPOX in colon cancer: A retrospective database study.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
A Comprehensive Board Review in Hematology and Medical Oncology 2013
The University of Texas, M. D. Anderson Cancer Center, Houston, Texas - 9/23/2013

Press Mentions

Radiopharm Theranostics Receives US FDA IND Approval for RAD 301 TechnologyDecember 30th, 2022
Montefiore Einstein Cancer Center Researchers Receive Price Family Foundation Health Equity Research AwardsMay 19th, 2022
Invasive Colorectal Cancer for 50 Years Reinforcement Case for Early DetectionFebruary 4th, 2020
Join now to see all